Financials
Income statement
Fiscal date | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
---|---|---|---|---|
Total reported revenue | — | 9.7B | 8.0B | 7.7B |
Cost of revenue | — | 5.0B | 4.1B | 4.0B |
Gross profit | — | 4.7B | 3.9B | 3.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | 3.5B | 3.1B | 2.8B |
Other operating expenses | — | 14M | — | 3M |
Operating income | — | 1.1B | 842M | 945M |
Non operating interest income | ||||
Income | — | 663M | 7M | 9M |
Expense | — | 72M | 98M | 67M |
Other income expense | — | — | — | — |
Pretax income | — | 1.7B | 751M | 887M |
Tax provision | — | 588M | 292M | 331M |
Net income | — | 1.1B | 459M | 556M |
Basic EPS | 32.9 | — | 15.7 | 19.1 |
Diluted EPS | 32.9 | — | 15.7 | 19.1 |
Basic average shares | 29.3M | — | 29.3M | 29.1M |
Diluted average shares | 29.3M | — | 29.3M | 29.1M |
EBITDA | — | 2.4B | 2.0B | 954M |
Net income from continuing op. | — | 1.7B | 2.3B | -625M |
Minority interests | — | -23M | 2M | 1M |
Preferred stock dividends | — | 0 | 0 | 0 |